Loading...
| Name | Option type | Quality (1-5)↓ | Topics | Created | |
|---|---|---|---|---|---|
Will NTLA-2002 receive FDA Breakthrough Therapy Designation by end of 2025?  | Binary | 2 | 2 months ago | ||
Will Intellia start Phase 3 trial of NTLA-2002 for HAE by end of 2025? | Binary | 2 | 2 months ago | ||
Will NTLA-2002 demonstrate over 90% attack reduction in Phase 3 by end of 2026? | Binary | 2 | 2 months ago | ||
Which in vivo CRISPR therapy will be first to receive FDA approval by 2026? | Categorical | 2 | 2 months ago | ||
When will Intellia complete Phase 3 study of NTLA-2002 by 2026? | Categorical | 2 | 2 months ago | ||
When will Intellia complete enrollment for Phase 3 study of NTLA-2002 by 2025? | Categorical | 2 | 2 months ago |